Novo Resources (NVO) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Novo Nordisk Says FDA Accepted New Drug Application for Wegovy PillMay 3 at 1:43 AM | msn.comNovo Nordisk shares jump as FDA accepts oral Wegovy applicationMay 2 at 8:43 PM | ca.investing.comNovo Nordisk says oral version of Wegovy accepted for FDA reviewMay 2 at 3:41 PM | msn.comNovo Nordisk to sell Wegovy through telehealth firms to cash-paying US customersApril 30, 2025 | msn.comNovo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 23%April 30, 2025 | msn.comNovo Nordisk ties up with three telehealth firms to expand Wegovy accessApril 29, 2025 | msn.comNovo Nordisk teams with telehealth firms Him, Ro to sell Wegovy at lower priceApril 29, 2025 | msn.com5NVO : Novo Nordisk's Options Frenzy: What You Need to KnowApril 23, 2025 | benzinga.comNovo Nordisk slides after Eli Lilly's results for oral weight loss drug—orforglipronApril 22, 2025 | msn.comTexas Health Resources sues over insulin prices, mirroring hundreds of other lawsuitsApril 19, 2025 | msn.comHighlights – March Quarter 2025April 16, 2025 | finance.yahoo.comNovo Resources: Highlights – March Quarter 2025April 16, 2025 | juniorminingnetwork.comNovo Resources Advances Exploration Projects in AustraliaApril 16, 2025 | tipranks.comNovo Resources Corp. Unveils New Corporate Presentation for Investors | NSRPF Stock NewsApril 9, 2025 | gurufocus.comNovo Resources Corp. Unveils New Corporate Presentation for InvestorsApril 9, 2025 | financialpost.comChulalongkorn, Novo Nordisk Partner to Tackle ObesityApril 7, 2025 | msn.comNovo Resources to Launch RC Drilling at Tibooburra Gold ProjectApril 1, 2025 | tipranks.comNovo Nordisk inks licensing pact with Lexicon for obesity candidateMarch 28, 2025 | msn.comNovo Nordisk to license obesity drug from Lexicon in up to $1 billion dealMarch 28, 2025 | msn.comLexicon Pharmaceuticals, Novo Nordisk strike obesity-drug license deal worth up to $1BMarch 28, 2025 | bizjournals.comNovo Nordisk-Minnesota deal to settle insulin lawsuit approvedMarch 26, 2025 | msn.comNovo Nordisk to Pay Up to $2 Billion for Rights to Experimental Obesity and Diabetes DrugMarch 24, 2025 | msn.comNovo Nordisk Strikes $2B Deal for Obesity DrugMarch 24, 2025 | msn.comNovo Resources: Aircore Drilling to Commence at Balla BallaMarch 19, 2025 | juniorminingnetwork.comNovo Nordisk Stock Rises Ahead of Data on Ozempic Ingredient's Ability to Lower Heart RiskMarch 17, 2025 | msn.comNovo Nordisk rebounds as Kepler upgrades Ozempic maker at long lastMarch 13, 2025 | msn.comROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVOMarch 12, 2025 | markets.businessinsider.comHalia Therapeutics Awarded Novo Nordisk Golden Ticket to Advance Obesity and Inflammation ResearchMarch 11, 2025 | finance.yahoo.comNovo Nordisk slips after data for next-gen obesity drugMarch 10, 2025 | msn.comROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVOMarch 6, 2025 | markets.businessinsider.comNovo Resources Corp prepares to begin drill targeting after geochemical sampling of John Bull and Tibooburra gold projectsFebruary 27, 2025 | au.investing.comNovo Resources Advances Exploration Amid ChallengesFebruary 26, 2025 | tipranks.comNovo Resources Corp. Exploration UpdateFebruary 26, 2025 | financialpost.comDrug compounders sue FDA over semaglutide status: reportFebruary 24, 2025 | seekingalpha.comNovo Nordisk A/S (NVO): Among Renaissance Technologies Portfolio’s Top Stock PicksFebruary 24, 2025 | insidermonkey.comFDA Declares Shortage of Novo Nordisk’s Wegovy, Ozempic OverFebruary 21, 2025 | msn.comU.S. attorneys general forum urges FDA to act against counterfeit weight loss drugsFebruary 21, 2025 | msn.comROSEN, A LEADING NATIONAL FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVOFebruary 13, 2025 | markets.businessinsider.comROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVOFebruary 5, 2025 | markets.businessinsider.comNovo Nordisk Annual Sales Jump on Higher Demand for Obesity DrugsFebruary 5, 2025 | nytimes.comNovo Resources Enhances Exploration Portfolio and Financial PositionFebruary 5, 2025 | tipranks.comNovo Nordisk Q4 Earnings: Outperformance Suggests Stock Price Comeback Starts TodayFebruary 5, 2025 | seekingalpha.comNovo Nordisk beats in Q4 as Wegovy sales more than doubleFebruary 5, 2025 | msn.comNovo Resources Corp. Business ReviewFebruary 5, 2025 | financialpost.comNovo Nordisk spikes as novel obesity drug causes up to 22% of weight lossJanuary 24, 2025 | msn.comFinally An Attractive Entry Point Into Novo NordiskJanuary 16, 2025 | seekingalpha.comNovo Nordisk seeks to block compounded VictozaJanuary 4, 2025 | msn.comElon Musk says he prefers Lilly’s Mounjaro over Novo’s OzempicDecember 26, 2024 | msn.comNovo Nordisk raises expectations for Eli Lilly after CagriSema slipupDecember 21, 2024 | msn.comNovo Nordisk Stock Crashes on Obesity Drug Data. It’s a Win for Eli Lilly.December 20, 2024 | yahoo.com Get Novo Resources News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Email Address NVO Media Mentions By Week NVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVO News Sentiment▼0.310.51▲Average Basic Materials News Sentiment NVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVO Articles This Week▼72▲NVO Articles Average Week Get Novo Resources News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 4Front Ventures News Today Algernon Pharmaceuticals News Today Allstar Health Brands News Today Anew Medical News Today Arno Therapeutics News Today AstraZeneca News Today AVAX Technologies News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:NVO) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Resources Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Resources With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
